Anti-inflammatory effects of enhanced external counterpulsation in subjects with abnormal glucose tolerance.
Elevated markers of systemic inflammation are associated with impaired glucose tolerance and type 2 diabetes mellitus. Enhanced external counterpulsation (EECP) has been shown to decrease circulating concentrations of pro-inflammatory markers in coronary artery disease patients. Here we provide novel evidence that EECP intervention also has a beneficial effect on circulating markers of systemic inflammation coincident with improvements in glycemic control in subjects with abnormal glucose tolerance.
Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611, USA. jemartin@lasell.edu
Jeffrey S
JS
Martin
Randy W
RW
Braith
D000368:Aged; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D015908:Counterpulsation; D018149:Glucose Intolerance / Q000097:blood / Q000628:therapy*; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000628:therapy*; D007333:Insulin Resistance; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D015415:Biomarkers; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein